Sanofi S.A. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi S.A. with three other
companies in this sector in the United States:
Merck & Co. , Inc.
sales of $39.81 billion
of which 88%
was Merck Pharmaceutical),
of which 58%
was Pharmaceuticals), and
of which 66%
was Innovative Medicines).
During the year ended December of 2016, sales at
Sanofi S.A. were $38.31 billion.
decrease of 0.4%
versus 2015, when the company's sales were $38.45 billion.
Contributing to the drop in overall sales was the 3.4% decline
in Vaccines, from $5.23 billion to $5.05 billion.
There were also decreases in sales in
Pharmaceuticals (down 1.8% to $32.28 billion)